We give you many useful information about health

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

We give you many useful information about health

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

We give you many useful information about health

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

We give you many useful information about health

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

We give you many useful information about health

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

Tampilkan postingan dengan label warning. Tampilkan semua postingan
Tampilkan postingan dengan label warning. Tampilkan semua postingan

Sabtu, 29 Oktober 2011

Do EU summits need a health warning?

AppId is over the quota
AppId is over the quota
Greece's Prime Minister George Papandreou (C) arrives at a news conference at the end of a euro zone summit in Brussels, October 27, 2011. REUTERS/Yves Herman

Greece's Prime Minister George Papandreou (C) arrives at a news conference at the end of a euro zone summit in Brussels, October 27, 2011.

Credit: Reuters/Yves Herman

By Dina Kyriakidou

ATHENS | Thu Oct 27, 2011 4:22pm EDT

ATHENS (Reuters) - In the small hours of Thursday, George Papandreou thanked his aides for helping clinch a second bailout deal for debt-ridden Greece, and admitted the strain had almost killed one of them.

"Some were under such pressure that they needed medical attention. I see George Zanias, thankfully with us. But George Glynos was unable to join us after suffering a heart attack," Papandreou told a news conference in Brussels after an 11-hour EU summit.

Like many of their EU counterparts, Greek officials have worked punishing hours under enormous stress for months. The debt crisis has taken its toll not only on their country and the euro, but on their health.

Government officials said Greece's chief economic adviser, Zanias, developed very high blood pressure during Sunday's summit and was ordered to stay in his room all day Monday. Papandreou's aide Glynos suffered a heart attack in Athens after Sunday's summit and missed Wednesday's meeting.

"Your body revolts. You go from a plane to meeting after meeting with little sleep, you drink too much coffee and you are forced to eat bad food. It's an unnatural life and there comes a point when we'll all pay for it," said a Greek Finance Ministry official who did not want to be named.

While leaders dined on giant shrimp with aubergines followed by roast turbot and a trio of sorbets, for the delegations, usually waiting anxiously to be briefed on a different floor, the dining is not as exciting.

"The food is terrible. You eat sandwiches and junk food all day. I got really sick from it Sunday," said one Greek delegate who declined to be named.

MARATHON MEETINGS

But even after a meal of roast turbot, the tension is just as high for the leaders meeting in a vast, windowless conference room in the upper reaches of the European Council's headquarters in Brussels.

They entered the building at around 5 p.m. Wednesday, and were still bargaining over a deal to rescue the euro zone from its debt crisis almost 11 hours later.

At around 2 a.m., when negotiations were at their peak, a team of around 15 medics gathered in the lobby of the brown marble-fronted Justus Lipsius building, although the reason was not immediately clear.

EU officials said the talks were extremely intense, with hard-nosed negotiation over very specific numbers before leaders would agree on the outline of a plan to reduce Greek debt and convince banks to take losses.

They knew their decisions had to reassure edgy financial markets, but could also cause big losses for financial institutions and perhaps lead to the nationalization of Greek banks.

One senior EU official said the talks progressed extremely slowly.

In the early hours of Thursday, French President Nicolas Sarkozy, German Chancellor Angela Merkel and the IMF's Christine Lagarde entered into direct negotiations with representatives of private sector banks and insurers to persuade them voluntarily to accept heavy losses on Greek debt.

At one point, euro zone negotiators said it might be necessary to force the banks and insurers to take losses if they didn't accept at least a 50 percent loss on their investments -- a move that would constitute an immediate default on Greek debt, with unpredictable fallout for Greece and the European economy.

Such a threat is likely to have caused enormous stress to the Greek team, which repeatedly said ahead of the summit that it wanted to do everything to avoid defaulting on its 210 billion euros of private sector debt.

HUGELY TIRING

"It is hugely tiring. You have to stay mentally focused, and it helps to be physically fit. You go to bed at maybe two in the morning and are up early. There's a huge amount of information you have to be able to process," said Michael Denison, special adviser to David Miliband when he was Britain's foreign secretary, and now research director for the London-based consultancy Control Risks.

EU summits are frequently high-pressure events. The leaders gather on the restricted upper floors of the building and barely move from the negotiating room until agreements are reached.

"It's a very unhealthy room, with no fresh air, and you don't know if it's day or night outside," the Greek delegate said. "During 11 hours of talks, the leaders took two half-hour breaks -- and that was not to rest, but to brief delegations."

The leaders usually sit around a vast oval table in the low-ceilinged wood-paneled room. Behind them is a separate table for aides and advisers, and on one side of the room a wall of glass booths contains the interpreters.

Summits are frequently heated and exhausting, with diplomats telling of heads of state who lose their temper or even fall asleep at critical moments. Not infrequently, they may go to change a shirt or freshen up when the strain begins to show.

One official half-jokingly said that supplies of fresh bottles of water to the meeting room are sometimes halted in order to add extra pressure on the negotiators to wrap it up.

"Part of the trick is to be able to move on from a topic immediately once a decision has been made," Denison said.

"But, however you do it, you need ministers who can keep the pace at these kind of meetings."

(Additional reporting by Luke Baker and Justyna Pawlak in Brussels, Peter Apps in London; Editing by Kevin Liffey)



New Automobile



Health Management

Jumat, 21 Oktober 2011

Disabled people benefits warning

AppId is over the quota
AppId is over the quota
21 October 2011 Last updated at 02:10 GMT Wheelchair Some 3.2 million people, including children, receive disability living allowance Many disabled people risk losing essential payments under planned benefits changes, a charity has warned.

Scope says the proposed test of claimants' need is flawed for focusing on the disability but ignoring relevant factors like housing and transport.

Thousands could be left with little or no financial support, Scope warns.

The government argues new payments will be more effectively targeted to those in greatest need, while cutting overpayments of £600m a year.

Some 3.2 million disabled people, including children, receive the existing disability living allowance.

It is in line to be replaced by the personal independence payment, which features in the government's Welfare Reform Bill.

A new medical assessment has been drawn up that will be carried out on disabled people of working age, of whom there are about two million.

But, according to Scope, that assessment "doesn't take into consideration all the barriers that disabled people face in daily life".

Continue reading the main story
I want to see money really getting to disabled people who need the help the most”

End Quote Maria Miler Minister for disabled people It highlights examples including unsuitable housing, inaccessible public transport, and a lack of informal support networks that "create significant extra costs for disabled people that in most cases are not related to the direct effect of an individual's condition and impairment".

Scope chief executive Richard Hawkes said: "We recognise that disability living allowance needs reforming and we fully support the government's ambitions to create a more active and enabling benefit."

But he added: "Without understanding the extent of barriers people face, the government has no hope to overcome them and genuinely enable people to take part in daily life."

The charity has designed an alternative assessment system that, it says, "will give disabled people the opportunity to address the barriers they face and therefore drive down costs in the long term, rather than placing a sticking plaster over them".

In response to the Scope report, minister for disabled people Maria Miller said: "At the moment disability living allowance doesn't have an in-built reassessment as part of it and we have £600m a year going out in overpayments as a result.

"I want to see that change so that the money is really getting to disabled people who need the help the most."



Debt Financing



Career Advisor

Senin, 10 Oktober 2011

Greece health warning after cuts

AppId is over the quota
AppId is over the quota
10 October 2011 Last updated at 00:23 GMT By James Gallagher Health reporter, BBC News People outside the parliament building in Athens protest against any further budget cuts (19 June 2011) Will cuts affect the long-term health of Greeks? Researchers have issued a warning about the health of people in Greece in the wake of the financial crisis.

Writing in The Lancet, they said cuts to hospitals' budgets meant they were being overstretched.

More people were reporting "bad health" and HIV infections were on the increase, the authors warned.

While public health experts said the picture was "concerning" they said it could take several years for the true health implications to fully emerge.

Greece has been at the centre of the economic turmoil in Europe and researchers say the austerity measures have taken a toll on health services.

"There were about 40% cuts in hospital budgets, understaffing, reported occasional shortage of medical supplies, and bribes given to medical staff to jump queues in overstretched hospitals," they wrote.

At the same time there was a 24% increase in public hospital admissions, partly fuelled by fewer patients using private hospitals.

An analysis of data from EU Statistics on Income and Living Conditions, comparing 2007 and 2009, showed a 15% increase in people not going to a doctor or dentist, mostly due "to long waiting times".

The researchers said: "We noted a significant rise [14%] in the prevalence of people reporting that their health was bad or very bad."

They also reported a decline in the number of people eligible for sickness benefit.

New infections of HIV were expected to increase by 52% in 2011, with half due to intravenous drug use.

Their report concludes: "Ordinary people are paying the ultimate price: losing access to care and preventative services.

"Greater attention to health and healthcare access is needed."

However, there is no data on the actual health of Greek citizens.

Dr Alexander Kentikelenis, of the University of Cambridge, told the BBC: "Many implications will take longer to show. In the Great Depression it took five-plus years for the effects to show in health in the US."



Debt Financing



Career Advisor

Sentamu warning on health reforms

AppId is over the quota
AppId is over the quota
8 October 2011 Last updated at 09:58 GMT Archbishop of York. Photo: Matthew Fearn/PA Dr Sentamu wants a national debate on the future of health care provision The Archbishop of York has warned of the dangers of introducing a more commercial culture into the National Health Service.

Dr John Sentamu, who had his appendix removed in May, said an NHS hospital could not be compared to a supermarket.

The archbishop said he was calling for a national debate on healthcare provision as politicians debate the Health and Social Care Bill.

The Department of Health said it "welcomed" the archbishop's comments.

Dr Sentamu was speaking after a meeting of the Archbishop of York's symposium, which brings together academics and practitioners to discuss a range of issues.

He said: "We must never allow health provision in this country to become exclusive.

"Decent healthcare should not solely be the preserve of those that can afford to purchase it."

Health inequalities

"Whilst we may strive to deliver value for money, we cannot allow care to be market-led or commercialised to the point where patient safety is put at risk."

Dr Sentamu said he was also concerned about social inequalities in healthcare provision and that problems could not be solved by "simply throwing money" at the system.

Calling for a national debate on the future of the NHS, the archbishop said: "We all want to see investment spent appropriately to provide the best care possible to as many people as possible.

"We all want to see a system that is compassionate and responsive. The challenge is how do we achieve that?"

A Department of Health spokesman said: "Our bill puts clear safeguards in place against any abuse from the private sector and ensures that all provision of services to NHS patients will be based on the quality of the service to patients, not the cost."



Debt Financing



Career Advisor

Selasa, 04 Oktober 2011

Stem-cell breast ops warning

AppId is over the quota
AppId is over the quota
30 September 2011 Last updated at 06:46 GMT By Neil Bowdler Health reporter, BBC News A surgeon performs liposuction The procedure involves grafting fat harvested from the patient by liposuction Senior plastic surgeons have issued a warning over a breast enlargement procedure being offered by private UK clinics.

The British Association of Aesthetic Plastic Surgeons (BAAPS) say "stem-cell breast augmentations" are unproven and should not be offered commercially.

The warning came at the group's annual conference in Birmingham.

One Harley Street clinic offering the surgery responded by saying they were "confident" the treatment was safe.

Research 'hijacked'

The surgery involves using fat harvested from the patient's stomach or thighs via liposuction and using it to build up the breast.

Prior to transplantation, around half of of the fat is processed to enrich the stem-cell content - naturally occurring regenerative cells found within the fat.

The hope is that this enrichment process can improve the prospects for the fat graft.

The same technology is being used in reconstructive surgery where "cell-enriched fat grafting" is now being offered in several centres around the world to reconstruct breasts following cancer surgery.

Trials are currently under way at NHS centres in London, Glasgow, Swansea, Norwich and North Tyneside.

But BAAPS believes more clinical testing needs to be done to establish its safety before it is used commercially on healthy women.

Continue reading the main story
We have to make sure whatever treatment we offer for breast augmentation is safe in the long-term”

End Quote Eva Weiler-Mithoff Consultant plastic surgeon "To think that this unproven research is hijacked and used in the commercial sector is really an appalling thought," former BAAPS president and consultant plastic surgeon Adam Searle told the BBC. "Not least when it's being utilised by inadequately trained practitioners."

Private London clinics, The Harley Street Skin Clinic and The Private Clinic of Harley Street, have been advertising stem-cell breast augmentations for some time. The latter says they will have treated some 200 patients by the end of this year.

In a statement, Dr Valentina Petrone of the The Private Clinic, said the views of BAAPS were welcome, but insisted the surgery was safe and every precaution was taken.

"The Private Clinic, is confident in respect to the safety of this treatment. Furthermore ongoing studies reassures us even more. We have strict patient selection criteria and clinical protocols in place.

"We, of course, look forward to completion of studies and any other findings as they become available over time and will, if necessary, adapt our protocols accordingly."

Cancer concern

The BAAPS warning came the same week new clinical data on cell-enriched fat grafting was presented to an conference in Nottingham.

Eva Weiler-Mithoff, a consultant surgeon at Canniesburn Plastic Surgery Unit in Glasgow, presented details of a 12-month trial to a meeting of the Oncoplastic Reconstructive Breast Surgery group.

The trial involved around 70 patients in seven centres in four countries. The data is yet to undergo peer review and was sponsored by Cytori Therapeutics, the US makers of a machine which can enrich the fat.

Consultant plastic surgeon Eva Weiler-Mithoff discusses the findings of a 12-month clinical trial

Ms Weiler-Mithoff told the BBC the procedure appears to be effective in cancer patients in filling in defects in the breast and in improving the appearance and feel of the breast. Nor were there any serious side-effects or recurrence of breast cancer to date.

"Traditional fat-grafting (in breast reconstructive surgery) does not work terribly well because there is not enough circulation to support the survival of the fat graft," she said.

"We know if we augment the fat graft with the naturally occurring regenerative cells in fat tissues we can improve the circulation around the fat graft and the survival of the fat graft."

But she said longer-term results were needed - at least five to10 years of data - before the technique could be deemed safe for use in cosmetic surgery.

"We still don't have enough long-term outcome data to say it's safe in the sense that it doesn't encourage the cancer to come back or new breast cancer to develop," she said.

"Because breast cancer is such a common disease we have to make sure whatever treatment we offer for breast augmentation is safe in the long-term."

A previous Japanese study involving 40 Japanese women undergoing cosmetic stem-cell breast augmentation also deemed the procedure to be effective, but also called for additional study.



Debt Financing



Career Advisor

Sabtu, 01 Oktober 2011

'Grave' health board cash warning

AppId is over the quota
AppId is over the quota
29 September 2011 Last updated at 16:12 GMT Surgical operation The boss of Cardiff and Vale University Health Board says it needs to save £87m and called for 'urgent action' The head of the health board for Cardiff and Vale of Glamorgan has warned staff its finances are in a "grave" state.

Cardiff and Vale University Health Board (UHB) has ordered a recruitment freeze and war on waste because of "unprecedented" financial pressures.

The board said it related largely to cost pressures, not to government cuts.

The health board's responsibilities include the University Hospital of Wales in Cardiff, Wales' largest.

In a "special edition" of a newsletter to staff this month, Cardiff and Vale chief executive Jan Williams says: "The current financial position is grave and I cannot stress enough the need for everyone to work together to meet the challenge."

'Urgent' Continue reading the main story
The current financial position is grave and I cannot stress enough the need for everyone to work together to meet the challenge”

End Quote Jan Williams Cardiff and Vale University Health Board "Urgent action" is needed to meet a legal obligation to break even by next March, she says.

The first half of the year has been "very challenging" and the board "faces unprecedented financial and performance pressures".

It needs to save £87.8m. Plans are in place for £56.3m, "some of which have risks that must be managed carefully".

As part of "immediate and decisive action to drive down costs", the board has decided to put an immediate hold on external recruitment. People will not be hired from outside without the chief executive's personal approval.

The cost of paying locum doctors and agency workers is being looked at, and a voluntary early release scheme is being offered to staff.

Ms Williams urges staff to "wage war on waste" and asks them to "be as flexible as possible" at work.

It comes at a time of mounting concern in Cardiff Bay about health service reorganisation.

'Damning indictment'

Conservative assembly leader Andrew RT Davies said: "The document is an extremely damning indictment of Labour's mismanagement of the Welsh NHS."

He attacked the Welsh Government for failing to maintain health spending - its biggest item of expenditure at £6bn - in line with inflation and called on Health Minister Lesley Griffiths to make a statement in the Senedd.

Mrs Griffiths said funding for health and social services had remained the same this year in cash terms. Cardiff and Vale health board's share was more than £1bn per year.

She said: "Yet again the Tories are wrong. We are not cutting the NHS budget.

"We had to take a number of tough decisions to protect the NHS budget as a result of the savage cuts imposed on Wales by the Tory-led UK Government.

Financial pressures

"Welsh Labour's commitment to the NHS - and its founding principles of care free at the point of need - is absolutely clear and supported by people all over Wales in the recent election."

A spokesman for the health board said the savings it needed to make were not due to cuts from the Welsh Government "but relates largely to cost pressures associated with the delivery of services, including inflation, additional staffing and drug costs".

"The financial pressures we face this year have been well documented and discussed openly at our public board meetings over a number of months," he said.

"The UHB is doing all it can to address these financial challenges, which includes working closely with staff and staff representatives to identify where resources can be released and waste reduced, while maintaining our high standard of patient care.

"It is absolutely right to involve staff in this way and it is disappointing that our efforts to engage staff in what is a critical debate are being reported in this way."



View the original article here



Peliculas Online

Stem-cell breast ops warning

AppId is over the quota
AppId is over the quota
30 September 2011 Last updated at 06:46 GMT By Neil Bowdler Health reporter, BBC News A surgeon performs liposuction The procedure involves grafting fat harvested from the patient by liposuction Senior plastic surgeons have issued a warning over a breast enlargement procedure being offered by private UK clinics.

The British Association of Aesthetic Plastic Surgeons (BAAPS) say "stem-cell breast augmentations" are unproven and should not be offered commercially.

The warning came at the group's annual conference in Birmingham.

One Harley Street clinic offering the surgery responded by saying they were "confident" the treatment was safe.

Research 'hijacked'

The surgery involves using fat harvested from the patient's stomach or thighs via liposuction and using it to build up the breast.

Prior to transplantation, around half of of the fat is processed to enrich the stem-cell content - naturally occurring regenerative cells found within the fat.

The hope is that this enrichment process can improve the prospects for the fat graft.

The same technology is being used in reconstructive surgery where "cell-enriched fat grafting" is now being offered in several centres around the world to reconstruct breasts following cancer surgery.

Trials are currently under way at NHS centres in London, Glasgow, Swansea, Norwich and North Tyneside.

But BAAPS believes more clinical testing needs to be done to establish its safety before it is used commercially on healthy women.

Continue reading the main story
We have to make sure whatever treatment we offer for breast augmentation is safe in the long-term”

End Quote Eva Weiler-Mithoff Consultant plastic surgeon "To think that this unproven research is hijacked and used in the commercial sector is really an appalling thought," former BAAPS president and consultant plastic surgeon Adam Searle told the BBC. "Not least when it's being utilised by inadequately trained practitioners."

Private London clinics, The Harley Street Skin Clinic and The Private Clinic of Harley Street, have been advertising stem-cell breast augmentations for some time. The latter says they will have treated some 200 patients by the end of this year.

In a statement, Dr Valentina Petrone of the The Private Clinic, said the views of BAAPS were welcome, but insisted the surgery was safe and every precaution was taken.

"The Private Clinic, is confident in respect to the safety of this treatment. Furthermore ongoing studies reassures us even more. We have strict patient selection criteria and clinical protocols in place.

"We, of course, look forward to completion of studies and any other findings as they become available over time and will, if necessary, adapt our protocols accordingly."

Cancer concern

The BAAPS warning came the same week new clinical data on cell-enriched fat grafting was presented to an conference in Nottingham.

Eva Weiler-Mithoff, a consultant surgeon at Canniesburn Plastic Surgery Unit in Glasgow, presented details of a 12-month trial to a meeting of the Oncoplastic Reconstructive Breast Surgery group.

The trial involved around 70 patients in seven centres in four countries. The data is yet to undergo peer review and was sponsored by Cytori Therapeutics, the US makers of a machine which can enrich the fat.

Consultant plastic surgeon Eva Weiler-Mithoff discusses the findings of a 12-month clinical trial

Ms Weiler-Mithoff told the BBC the procedure appears to be effective in cancer patients in filling in defects in the breast and in improving the appearance and feel of the breast. Nor were there any serious side-effects or recurrence of breast cancer to date.

"Traditional fat-grafting (in breast reconstructive surgery) does not work terribly well because there is not enough circulation to support the survival of the fat graft," she said.

"We know if we augment the fat graft with the naturally occurring regenerative cells in fat tissues we can improve the circulation around the fat graft and the survival of the fat graft."

But she said longer-term results were needed - at least five to10 years of data - before the technique could be deemed safe for use in cosmetic surgery.

"We still don't have enough long-term outcome data to say it's safe in the sense that it doesn't encourage the cancer to come back or new breast cancer to develop," she said.

"Because breast cancer is such a common disease we have to make sure whatever treatment we offer for breast augmentation is safe in the long-term."

A previous Japanese study involving 40 Japanese women undergoing cosmetic stem-cell breast augmentation also deemed the procedure to be effective, but also called for additional study.



View the original article here



Peliculas Online

Jumat, 30 September 2011

Warning over heart patient drugs

AppId is over the quota
AppId is over the quota
28 September 2011 Last updated at 13:44 GMT Arteriogram of arteries of healthy heart The report reviewed cardiology services across Scotland More than half of heart patients in Scotland at high risk of stroke are not receiving the most appropriate treatment, according to a new report.

Scrutiny body Healthcare Improvement Scotland has published the "most comprehensive picture yet" of cardiology services across the country.

It found 53% of patients who should be getting a blood thinning drug were not.

Meanwhile low-risk patients are being given more powerful medication when they should just be taking aspirin.

The report paints an in-depth picture of the strengths and weaknesses of heart disease services in Scotland, and includes detailed plans for how improvements to services can be made.

Cardiovascular disease is the leading cause of death in the UK and coronary heart disease results in nearly 10,000 deaths every year in Scotland.

The report raised concerns about treatments prescribed to people with atrial fibrillation, a common heart rhythm disorder with a high risk of stroke.

While nearly 80% of people with this diagnosis receive some form of blood-thinning drug, less than half (47%) of higher risk patients are receiving the most appropriate treatment, Warfarin.

At the same time 31% of low-risk patients, who should be treated with aspirin alone, are receiving a blood-thinning drug which exposes them unnecessarily to a higher risk of bleeding complications.

Vital services

Dr Martin Denvir, clinical lead for the heart disease improvement programme, said: "Within three years of starting this improvement programme we are now publishing a groundbreaking report which sets out in detail just what has been achieved in Scotland - and what is still to be done.

"This is the most comprehensive picture yet of heart disease services in Scotland.

Continue reading the main story
There is some way to go until every patient has the correct treatment every time”

End Quote David Clark Chest Heart & Stroke Scotland "The journey towards perfect care for all patients is by no means over, but our findings clearly identify what is already being done well, what needs improvement and how we can measure our improvement and progress towards best quality of care."

The report also found that although all health boards have risk assessment programmes in place to identify people at high risk of heart disease and stroke, these programmes are not provided comprehensively for all high-risk groups in the general population.

It also said the Scottish Ambulance Service provides a well-trained and rapid response to emergency calls and reaches 71% of patients with suspected heart disease within eight minutes.

The report makes a number of key recommendations to improve patient care, including a review of the prescribing of blood-thinning drugs.

It said patients at low risk of stroke should not routinely be prescribed Warfarin.

Andy Carver from the British Heart Foundation (BHF) welcomed the report and said: "It is an important step in improving the accountability of NHS boards for the delivery of vital services for heart patients.

"We will continue to watch closely and help ensure that these standards are implemented to help people prevent heart disease and make sure services for heart patients are the best possible in all parts of the country."

Chest Heart & Stroke Scotland's chief executive David Clark said "We recognise that there has been real progress as a result of the Heart Disease Improvement Programme and that Scotland has some world-class centres for the treatment of heart disease.

"However, we also have to recognise that there is some way to go until every patient has the correct treatment every time."



View the original article here



Peliculas Online

Rabu, 28 September 2011

Warning of cancer cost 'crisis'

AppId is over the quota
AppId is over the quota
26 September 2011 Last updated at 10:26 GMT By James Gallagher Health reporter, BBC News Robotic surgery The cost-effectiveness of minimally invasive robotic surgery is questioned The cost of treating cancer in the developed world is spiralling and is "heading towards a crisis", an international team of researchers says.

Their Lancet Oncology report says there is a "culture of excess" with insufficient evidence about the "value" of new treatments and technologies.

It says the number of cancer patients and the cost of treating each one is increasing.

It argues for reducing the use and analysing the cost of cancer services.

About 12 million people worldwide are diagnosed with cancer each year. That figure is expected to reach 27 million by 2030.

The cost of new cancer cases is already estimated to be about £185bn ($286bn) a year.

Rising costs

A group of 37 leading experts from around the world say the burden of cancer is growing and becoming a major financial issue.

Their report says most developed countries dedicate between 4% and 7% of their healthcare budgets to dealing with cancer.

"The issue that concerns economists and policymakers is not just the amount of money spent on healthcare, but also the rate of increase in healthcare spending or what has become known as the cost curve."

It says the UK's total spend on breast cancer has increased by about 10% in each of the past four years.

"In general, increases in the cost of healthcare are driven by innovation. We spend more because we can do more to help patients."

For example, the number of cancer drugs available in the UK has risen from 35 in the 1970s to nearly 100, but the report warns they can be "exceedingly expensive".

It adds: "Few treatments or tests are clear clinical winners, with many falling into the category of substantial cost for limited benefit."

The cost of drugs is not the only target for criticism.

Lead author Prof Richard Sullivan told the BBC: "It's not just pharmaceuticals. Biomarkers, imaging and surgery are all getting through with very low levels of evidence - the hurdles are set too low."

The report calls for a proper evaluation of the relative merits of conventional surgery and less invasive robotic surgery.

Too much

Another criticism is "overusing" treatments and technologies.

Continue reading the main story

All cancers are not the same, even all breast or lung cancers are not the same.

It is hoped that better testing will bring about an era of "personalised medicine", meaning drugs can be tailored to specific cancers.

In Japan, testing for the KRAS gene in colorectal cancer patients before deciding whether to use a cancer drug saves £32m per year.

However, the report says that on the whole "the science has not lived up to the promise".

"It is often easier to order a scan than to reassure the patient or physician on the basis of a careful history and a physical examination," the report claims.

There is also criticism of "futile care" - providing expensive chemotherapy which gives no medical benefit in the last few weeks of a patient's life.

Prof Sullivan said: "We're on an unaffordable trajectory. We either need to manage and reduce the costs or the cost will increase and then inequality rises between rich and poor."

He said failure to manage costs could result in a "train crash".

The report says solutions fall into two categories: reducing the cost of services or reducing the number of people using them.



View the original article here



Peliculas Online

Jumat, 16 September 2011

HEALTH MANAGEMENT. Outbreak of Listeria warning prompt, voluntary recall of Ford rock cantaloupe

Health officials have issued a warning for cantaloupes area producers of melon revered the Ford rock of the State of Colorado, to the United States in an outbreak of bacteria blamed for four deaths in the State and the Mexico New, disturbing of farmers who depend on sales of the fruit.
The warning of the Centers for Disease Control and Prevention came after many cases of a strain of Listeria have been reported in six States, including at least 11 Colorado, 10 of the New-Mexico, two in Texas and one each in Indiana, Nebraska and Oklahoma.
The Agency said that it is the first outbreak of Listeria associated with cantaloupe in the United States. The U.S. Food & Drug Administration said that he had not recalled melons, while working to locate the source.
Update: Jensen firm in Holly, Colorado, is voluntarily recalling cantaloupe that it shipped to Illinois, Wyoming, Tennessee, Utah, Texas, Colorado, Minnesota, Kansas, New-Mexico, North Carolina, Missouri, Nebraska, Oklahoma, Arizona, New Jersey, New York and Pennsylvania between July 29 and September 10.
Rocky cantaloupes Ford, named for an area along the old Santa Fe Trail about 130 miles (200 km) southeast of Denver, are appreciated for their above average sugar content. W.C. Fields told bald guys have "a head shaped like a cantaloupe Rocky Ford", and Lucile Ball had delivered to his dressing room melons.
"This is really ridiculous." You can obtain Listeria any where. "Melons to eat every day," said Kent Lusk, a fifth generation farmer cantaloupe of Rocky Ford.
Commissioner of the Colorado Agriculture, John Salazar, said that the contamination has perhaps not cantaloupe, but a truck or other source. But several Colorado grocery chains pulled their supplies as a precautionary measure, and at the New-Mexico issued a voluntary recall. State Bureau of environmental health inspectors have been collecting samples of cantaloupe grocery stores and distributors across the New Mexico for laboratory analysis.
Listeriosis is a serious infection usually caused by ingestion of food contaminated with Listeria monocytogenes. The disease primarily affects the elderly, pregnant women, infants and adults with weakened immune systems.
Director of the health of the Colorado Chris Urbina said of people who are the people of included high risk 60 and older, those whose immune system is weakened of transplants and persons with chronic diseases. Symptoms may include fever, muscle aches, diarrhea, headache of head, neck stiffness, confusion and seizures. Listeriosis can cause miscarriages and stillbirths.
The CDC warning advised people with cantaloupes home to see if they came from the region of Rocky Ford and if yes, do not eat melons are in a group vulnerable. Health application people throw cantaloupes Rocky Ford put them in a closed plastic bag before putting them in the trash.
The fatal cases in the New-Mexico included a man 93 years old, originally from the County of Bernalillo, a 61-year-old woman, originally from the County of Curry and a man of 63 years, originally from the County of Bernalillo. Mark Salley, spokesman for the Department of the Colorado public health and environment, said the deceased in Colorado was not to be identified.